default author photo

Dan Liu

Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)

SCHOLARLY PAPERS

2

DOWNLOADS

153

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Immune Microenvironment Spatial Landscapes of Tertiary Lymphoid Structures in Gastric Cancer

Number of pages: 31 Posted: 28 Oct 2024
Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) and Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
Downloads 79 (809,932)

Abstract:

Loading...

Gastric cancer, Tertiary lymphoid structures, Tumour microenvironment, Prognostic model, Single-cell RNA sequencing, Spatial transcriptomics

2.

A Phase Ib Study of KN026, a Bispecific Anti-HER2 Antibody, Combined with KN046, an Anti-CTLA-4/PD-L1 Antibody, in Patients with HER2-Positive Advanced Gastrointestinal Cancer

Number of pages: 33 Posted: 07 May 2022
Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Zhengzhou University - Henan Cancer Hospital, Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) and Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
Downloads 74 (852,604)
Citation 1

Abstract:

Loading...

Gastrointestinal cancer, Bispecific antibody, Anti-HER2 therapy, Immunotherapy.